Key facts
- Lifespin’s last known valuation is $43.4M (Jan 2025).
- It has raised $26.8M; the latest was Later Stage VC ($10.3M) in Jan 2025.
- Notable investors include Wieland Capital, Discovery Ventures (Berlin), Yapay Zeka Fabrikasi.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Lifespin
- ·The full record, as it builds
Funding rounds
No funding rounds for Lifespin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lifespin
Developer of a cloud and AI(artificial intelligence)-based health diagnostics platform designed to set a standard for efficiency, prevention, and personalization. The company's platform transforms blood samples into digital samples and generates the digital twin of patients based on the measurement of metabolism in blood by AI-improved NMR(Nuclear Magnetic Resonance), providing clients with moderate-cost health testing for preventative care, diagnostics, and treatment.
- Sector
- Healthcare
- HQ
- Regensburg, Germany
- Founded
- 2017
- Employees
- 23
- Website
- lifespin.health/
- Ownership
- Privately Held (backing)
Lifespin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lifespin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lifespin in its N-PORT filings yet. We sweep new filings monthly.